Director TitleAgeSince
Chairman - -
Chairman - 2012-06-27
Director/Board Member - 2012-12-23
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 23.15M
-0.80%+5.16%-0.70%+12.87% 48.95B
-4.40%+14.28%+23.70%+5.89% 40.75B
+4.37%-0.24%+408.71%+617.33% 38.46B
-2.02%-1.87%+6.91%+49.69% 36.38B
+5.56%+11.70%+11.64%+51.50% 28.45B
-1.37%-1.40% - - 16.62B
-1.08%-4.51%+32.14%+128.49% 16.33B
-7.03%-2.55%-8.55%-33.98% 13.65B
-0.06%+3.75%+3.81%+9.62% 13.56B
Average -0.53%+6.06%+59.71%+105.18% 28.13B
Weighted average by Cap. -0.29%+7.20%+74.81%+125.36%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock